In this longitudinal study, we showed that APOE ε4 carriers in Aβ‐positive subjects were associated with a faster cognitive decline, independent of tau load, providing evidence that APOE ε4 with Aβ pathology exhibit an increased rate of dementia over time. This evidence concerns the gene APOE and dementia.